Inequalities Across 46 European Countries in Clinical Eligibility Criteria for the Start of A First (Reimbursed) Biologic in Patients with Rheumatoid Arthritis.
AuthID
P-002-4R2
P-002-4R2
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service